FDA Drug recall D-0330-2015
Gabapentin Capsules, USP 300 mg, 100-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141
- FDA Drug
- Class II
- terminated
- Published 2015-01-14
On 2015-01-14 the FDA classified a Class II recall of Gabapentin Capsules, USP 300 mg, 100-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141 by Aurobindo Pharma Usa, citing failed Tablet/Capsule Specifications: Complaints of empty capsules received.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0330-2015 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-10-17 |
| Published | 2015-01-14 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Aurobindo Pharma Usa |
| Distribution | US |
Product
Gabapentin Capsules, USP 300 mg, 100-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141; Manufactured by: Aurobindo Pharma Limited, Unit-VII (SEZ), Mahaboob Nagar (Dt), AP-509302, INDIA, NDC 16714-662-01, UPC 3 16714-662-01 5.
Reason
Failed Tablet/Capsule Specifications: Complaints of empty capsules received.
Identifiers
| upc | 316714662015 |
|---|---|
| ndc | 16714-661-01 |
| ndc | 16714-661-02 |
| ndc | 16714-661-03 |
| ndc | 16714-662-01 |
| ndc | 16714-662-02 |
| ndc | 16714-662-03 |
| ndc | 16714-663-01 |
| ndc | 16714-663-02 |
| code_info | Lot #: GESB14011-A, Exp 12/15 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0330-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.